Please use this identifier to cite or link to this item:
http://dx.doi.org/10.25673/115577
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dahley, Carolin | - |
dc.contributor.author | Böckmann, Tim | - |
dc.contributor.author | Ebert, Andrea | - |
dc.contributor.author | Goss, Kai-Uwe | - |
dc.date.accessioned | 2024-04-05T06:35:42Z | - |
dc.date.available | 2024-04-05T06:35:42Z | - |
dc.date.issued | 2024 | - |
dc.identifier.uri | https://opendata.uni-halle.de//handle/1981185920/117530 | - |
dc.identifier.uri | http://dx.doi.org/10.25673/115577 | - |
dc.description.abstract | Membrane permeability is one of the main determinants for the absorption, distribution, metabolism and excretion of compounds and is therefore of crucial importance for successful drug development. Experiments with artificial phospholipid membranes have shown that the intrinsic membrane permeability (P0) of compounds is well-predicted by the solubility-diffusion model (SDM). However, using the solubility-diffusion model to predict the P0 of biological Caco-2 and MDCK cell membranes has proven unreliable so far. Recent publications revealed that many published P0 extracted from Caco-2 and MDCK experiments are incorrect. In this work, we therefore used a small self-generated set as well as a large revised set of experimental Caco-2 and MDCK data from literature to compare experimental and predicted P0. The P0 extracted from Caco-2 and MDCK experiments were systematically lower than the P0 predicted by the solubility-diffusion model. However, using the following correlation: log P0,Caco-2/MDCK = 0.84 log P0,SDM – 1.85, P0 of biological Caco-2 and MDCK cell membranes was well-predicted by the solubility-diffusion model. | eng |
dc.language.iso | eng | - |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | - |
dc.subject.ddc | 540 | - |
dc.title | Predicting the intrinsic membrane permeability of Caco-2/MDCK cells by the solubility-diffusion model | eng |
dc.type | Article | - |
local.versionType | publishedVersion | - |
local.bibliographicCitation.journaltitle | European journal of pharmaceutical sciences | - |
local.bibliographicCitation.volume | 195 | - |
local.bibliographicCitation.pagestart | 1 | - |
local.bibliographicCitation.pageend | 8 | - |
local.bibliographicCitation.publishername | Elsevier | - |
local.bibliographicCitation.publisherplace | New York, NY [u.a.] | - |
local.bibliographicCitation.doi | 10.1016/j.ejps.2024.106720 | - |
local.openaccess | true | - |
dc.identifier.ppn | 1885084293 | - |
cbs.publication.displayform | 2024 | - |
local.bibliographicCitation.year | 2024 | - |
cbs.sru.importDate | 2024-04-05T06:35:23Z | - |
local.bibliographicCitation | Enthalten in European journal of pharmaceutical sciences - New York, NY [u.a.] : Elsevier, 1993 | - |
local.accessrights.dnb | free | - |
Appears in Collections: | Open Access Publikationen der MLU |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S0928098724000319-main.pdf | 1.34 MB | Adobe PDF | View/Open |